---
document_datetime: 2023-09-21 18:04:13
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/hexavac-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: hexavac-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.2822502
conversion_datetime: 2025-12-20 00:22:05.211045
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Steps taken after granting the Marketing Authorisation

For procedures finalised after 1 October 2002 please refer to module 8B.

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

| Scope                                                                                                                  | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Clinical changes (additional primary dose schedule)                                                                    | II/0001              | II                       | 27.06.01                            | 24.10.01                                 |
| Change in container shape                                                                                              | I/0003               | I                        | 27.06.01                            | -                                        |
| Changes to comply with supplements to pharmacopoeias                                                                   | I/0004               | I                        | 27.06.01                            | -                                        |
| Change in specifications of active substance                                                                           | I/0005               | I                        | 27.06.01                            | -                                        |
| Quality changes                                                                                                        | II/0006              | II                       | 20.09.01                            | 23.10.01                                 |
| Quality change Minor change of manufacturing process of the active substance                                           | I/0007               | I                        | 27.06.02                            | - authorised                             |
| Quality change : Minor change of manufacturing process of the active substance                                         | I/0008               | I                        | 27.06.02                            | -                                        |
| Quality change: Quality: Update of or change(s) to the pharmaceutical documentation                                    | II/0009              | II                       | 27.06.02                            | 02.07.02                                 |
| Quality change Change(s) to the test method(s) and/or specifications for the active substance and the finished product | II/0010              | II                       | 25.04.02                            | 06.05.02                                 |
| Quality change: Change to comply with supplements to pharmacopoeias.                                                   | I/0011               | I                        | 12.04.02                            | -                                        |
| Quality change: Change in supplier of an intermediate compound used in manufacture of the active substance.            | I/0012               | I                        | 09.07.02                            | -                                        |

In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

<!-- image -->